沙鲁辛α通过YAP/ZO-1信号通路在高血压中保留了质内皮屏障功能
Lang Li1, Huan Wang2, ChunYu Zhao1
1Department of Nephrology, The Third Clinical Medical College of Three Gorges University, No. 60 Qiaohu 1st Road, Xiling District, Yichang, Hubei 471003, China; Sinopharm Gezhouba Central Hospital, No. 60 Qiaohu 1st Road, Xiling District, Yichang, Hubei 471003, China.
Peptides
|September 19, 2025
概括
素α通过保持球壁垒功能的保护,防止高血压性脏病. 它抑制YAP/ZO-1通路,减少高血压小鼠和细胞的炎症和白蛋白尿.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心血管生物学 心血管生物学
- 分子生物学分子生物学
背景情况:
- 高血压性病 (HN) 是末期病的主要原因,其特征是质内皮功能障碍和炎症.
- 一种生物活性,Salusin-α具有潜在的心血管益处,但其在HN中的作用尚不清楚.
研究的目的:
- 为了研究Salusin-α对高血压脏病中质内皮屏障功能的保护作用.
- 阐明涉及YAP/ZO-1信号通路的潜在机制.
主要方法:
- 雄性C57BL/6小鼠接受了血管激素II/高盐 (ANG/HS) 高血压,有或没有Salusin-α治疗.
- 人类囊内皮细胞 (HRGEC) 用于评估屏障功能和信号通路.
- 测量包括血清/脏Salusin-α水平,炎症标志物,白蛋白尿,ZO-1表达和YAP核转位.
主要成果:
- 患有高血压的小鼠显示Salusin-α水平降低,炎症增加,白蛋白尿和ZO-1下调.
- 沙鲁辛-α治疗剂量依赖地恢复了ZO-1表达和减少了白尿.
- 在HRGEC中,Salusin-α通过抑制YAP核转位和保存ZO-1来减轻ANG/HS诱导的屏障功能障碍.
结论:
- 沙鲁辛-α通过抑制YAP介导的ZO-1降解来缓解高血压性损伤,从而保持质内皮屏障功能.
- 沙鲁辛-α显示出作为针对高血压脏病的YAP/ZO-1轴的治疗剂的潜力.
关键词:
淋巴细胞的过功能在高血压的高血压.萨鲁辛-α是一种素.哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈ZO-1 是一个ZO-1更多相关视频
相关概念视频
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
2.3K
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
01:25Antihypertensive Drugs: Direct Renin Inhibitors
1.3K
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
1.3K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
2.5K
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.5K
01:29Hypertension II: Pathophysiology
803
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
803
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
2.2K
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
2.2K
01:33Hormonal Regulation
35.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
35.7K